MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹78 Cr | ₹85 Cr | ₹83 Cr | ₹73 Cr | ₹53 Cr |
What is the latest Total Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹85 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | ₹53 Cr |
How is Total Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹78 Cr | -7.56 | |
| Mar2024 | ₹85 Cr | 2.40 | |
| Mar2023 | ₹83 Cr | 13.60 | |
| Mar2022 | ₹73 Cr | 36.45 | |
| Mar2021 | ₹53 Cr | - | |
Compare Total Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹400.8 Cr | 3.7% | -15.5% | -45.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 3.7% |
-15.5% |
-45.1% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses